title: Prospective evaluation of the prevalence of factor V Leiden mutation in portal or hepatic vein thrombosis.
authors.forename: M H
authors.initials: MH
authors.lastname: Denninger
authors.forename: D
authors.initials: D
authors.lastname: Helley
authors.forename: D
authors.initials: D
authors.lastname: Valla
authors.forename: M C
authors.initials: MC
authors.lastname: Guillin
mesh_terms: D016736:Antiphospholipid Syndrome / Q000150:complications / Q000453:epidemiology; D006502:Budd-Chiari Syndrome / Q000097:blood / Q000453:epidemiology / Q000209:etiology / Q000235:genetics*; D015897:Comorbidity; D004198:Disease Susceptibility; D004789:Enzyme Activation; D005165:Factor V / Q000032:analysis* / Q000235:genetics; D005260:Female; D005602:France / Q000453:epidemiology; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D008297:Male; D009196:Myeloproliferative Disorders / Q000150:complications / Q000453:epidemiology; D011169:Portal Vein; D015995:Prevalence; D011446:Prospective Studies; D011486:Protein C / Q000378:metabolism; D012307:Risk Factors; D019851:Thrombophilia / Q000453:epidemiology* / Q000209:etiology / Q000235:genetics; D013927:Thrombosis / Q000097:blood / Q000453:epidemiology / Q000209:etiology / Q000235:genetics*
chemical_list: D011486:Protein C; C095381:factor V Leiden; D005165:Factor V